The XR digital integration workstation, as a software and hardware integrated platform that combines PC, VR, and MR ...

BMS is also testing Reblozyl in the phase 3 INDEPENDENCE trial as a treatment for anaemia in patients with myelofibrosis already being treated with JAK inhibitor drugs.

Bristol-Myers Squibb has claimed its second FDA approval in just a few days for its Opdivo/Yervoy combination, this time in liver cancer.

The world's biggest electric bus maker goes to some extraordinary lengths, and uses some innovative tech, to ensure battery pack safety.